Spain's Almirall to buy U.S. dermatology portfolio from Allergan

Aug 3 (Reuters) - Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.

Almirall said it would pay $550 million in cash upfront and that there is a possibility of an earn-out of up to $100 million based on business performance.

AUGUST 3б 2018

https://www.reuters.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company